Leading experts in Molecular Imaging and Nuclear Medicine advising MILabs
Otto C. Boerman studied Chemistry at the University of Nijmegen where he also was a junior investigator at the Department of Cell Biology. As a fellow of the Dutch Cancer Society he worked at the Center for Molecular Medicine and Immunology in Newark (NJ) and at the Biological Response Modifiers Program of the National Institutes of Health in Frederick (MD). His preclinical research group in Nijmegen focuses on radionuclide imaging and therapy with radiolabeled peptides and antibodies. He is a member of the editorial board of The Journal of Nuclear Medicine and The European Journal of Nuclear Medicine & Molecular Imaging. He is a (co-)author of more than 300 peer reviewed scientific publications.
Rudi Dierckx heads the Department Head of Nuclear Medicine and Molecular Imaging at the University Medical Center Groningen (UMCG). His research is focused on the development of new nuclear imaging methods and radiopharmaceuticals, and the evaluation of existing procedures. Next to being specialized in Nuclear Medicine Prof. Dierckx is also a trained Neuropsychiatrist and has a Master’s degree in Business Administration.
Dr. G. Allan Johnson is the Charles E. Putman University Professor of Radiology, Physics, and Biomedical Engineering. Dr. Johnson received his PhD from Duke University in 1974 in electron spin resonance under Walter Gordy and has been in the Department of Radiology since 1974, where he is currently Director of Diagnostic Physics. He holds joint appointments in Radiology, Physics, and Biomedical Engineering, and he is co-author on over 300 peer-reviewed papers. Dr. Johnson is involved in both the engineering physics required to extend the resolution of MR imaging and in a broad range of applications in the basic sciences.
Dr. Rob F. Mudde has been Vice-Rector Magnificus/Vice-President Education in the Executive Board of Delft University of Technology since 1 March 2018. He is Professor of Multiphase Flow and Distinguished Professor of Science Education.
Rob Mudde has a long track record at TU Delft. He has filled various scientific and managerial positions with the university since 1988. Until his appointment as Vice-Rector Magnificus/Vice-President, he was interim chairman of the Imaging Physics department at the Faculty of Applied Sciences and headed the TU Delft Teaching Academy and the Teaching Lab.
Dr. Pomper is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. He is also a Professor of Oncology and Radiation Oncology and Molecular Radiation Services. He is an internationally recognized leader in molecular imaging research and develops and implements new imaging agents that target cancer and brain disorders. He is the recipient of the William R. Brody Professor of Radiology, a professorship designated for a radiologist physician scientist who excels in translational innovation in imaging. Dr. Pomper’s interests are in the development of new radiopharmaceuticals, optical probes and techniques for molecular imaging of cancer and central nervous system disease. He is the Editor-in-Chief of the journal Molecular Imaging.
Vesna Sossi is a Professor in the Physics and Astronomy Department at the University of British Columbia (UBC) and Director of the UBC Positron Emission Tomography imaging group. Her research is focused on quantitative PET imaging, algorithms and data modelling and interpretation, with emphasis on neurodegeneration in humans and small animal models of disease. Her work on Molecular Imaging (in particular PET) and application to unravel mechanisms of Parkinson Disease is recognized worldwide e.g. through widely cited publications in Science and high ranked imaging and neuroscience journals.
Dr. Tsui did his postdoctoral training at and was on the faculty of the University of Chicago before joining the Department of Biomedical Engineering and the Department of Radiology at the University of North Carolina at Chapel Hill in 1982. His research interest is in medical imaging, particularly in the area of Single-Photon Computed Emission Tomography (SPECT), Positron Emission Tomography (PET), and magnetic resonance imaging (MRI). Specific research projects include imaging theory, Monte Carlo simulation, collimator design, image evaluation, two-dimensional and three-dimensional image reconstruction algorithm development, and quantitative SPECT imaging techniques. He is a PI of 5 NIH and DOD research grants and subcontracts and heads the Medical Imaging Physics Program within the Department of Radiology at Johns Hopkins Medicine.
Fred Verzijlbergen is a nuclear medicine specialist with 30+ years of experience as a doctor, professor, and president of leading international bodies such as the Dutch Society of Nuclear Medicine (NVNG) and the European Association of Nuclear Medicine (EANM).
After years of experience in internal- and nuclear medicine in a large general hospital, he became a full professor. Apart from this, he is also specialized in nuclear cardiology, brain SPECT and PET, and imaging and therapy in oncology including nuclear prostate cancer imaging and treatment. As part of his role as head of the department, he was also responsible for HR- and budgetary issues, regulatory affairs, and investments in staff/equipment.
Prof. Erik Verburg, MD Ph.D. is currently professor of Translational Nuclear Medicine and consultant physician in Nuclear Medicine at the Erasmus MC, Rotterdam. Before that, he absolved his training in Nuclear Medicine in Utrecht (Netherlands) and Würzburg (Germany) and gathered experience in clinical as well as preclinical nuclear medicine as an assistant professor of Nuclear Medicine at the University Hospital Aachen (Germany) and as full professor of Experimental Nuclear Medicine at the University of Marburg, where he gained extensive experience with both imaging and therapy using radionuclides in both humans and small animals, as well with setting up small animal imaging facilities. His current research focus is translational nuclear medicine going from lab to patient and back again, including the development of alternative new animal models based on invertebrates.